CVR 16313440Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)KastrupFounded 1 Aug 1992
Employees
508
CVR registry, Aug 2026
-136 (-21.1%) over 12 months
Revenue
1.7B
DKK, annual report 2025
+2.4% on 2024
Result
+49M
DKK, annual report 2025
Equity
315.2M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about FERRING PHARMACEUTICALS A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexFerring B.V.100% of capital and votes, since 1 Jan 1997
Jan Peutzfeldtsince 1 Feb 2024
Kim Fonager Jensensince 10 Dec 2021
Jesper Thomsensince 15 Sep 2025
and 1 more100% of capital and votessince 1 Jan 1997
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
24 Aug 2005 to 1 Nov 2026.
13 Mar 1980 to 1 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,005,468 | 1,261,432 | 1,457,509 | 1,690,294 | 1,730,413 |
| Operating profit | +54,035 | +66,540 | +88,956 | +103,162 | +120,592 |
| Result for the year | +40,174 | +52,377 | +67,110 | +76,890 | +49,005 |
| Equity | 69,618 | 121,995 | 189,325 | 266,214 | 315,220 |
| Total assets | 472,880 | 485,671 | 586,405 | 554,485 | 671,064 |
| Employees (average) | 487 | 559 | 578 | 601 | 577 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | -4.4% | 25.5% | 15.5% | 16% | 2.4% |
| EBIT margin (overskudsgrad) | 5.4% | 5.3% | 6.1% | 6.1% | 7% |
| EBITDA | 70,559 | 97,748 | 118,185 | 133,251 | 150,777 |
| EBITDA margin | 7% | 7.8% | 8.1% | 7.9% | 8.7% |
| Employee growth (vækst i antal ansatte) | -2% | 12.5% | 3.4% | 4% | -4% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -31note 1 | -309note 1 | -1,250note 1 | -349note 1 | 0note 1 |
| Gearing, NIBD / EBITDA | Net cashnote 1 | Net cashnote 1 | Net cashnote 1 | Net cashnote 1 | Net cashnote 1 |
| ROIC (afkast af investeret kapital) | 56.1%note 1 | 57%note 1 | 44.7%note 1 | 35.3%note 1 | 32.4%note 2 |
| Capex (investeringer i anlægsaktiver) | 100,293 | 72,314note 3 | 17,916note 4 | 10,492note 4 | 9,963note 4 |
| Capex % of sales (investeringer i procent af omsætningen) | 10% | 5.7%note 3 | 1.2%note 4 | 0.6%note 4 | 0.6%note 4 |
| FCFF / EBITDA (pengestrømskonvertering) | -116.1% | Not reported | Not reported | Not reported | Not reported |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -10,481note 1 | -16,852note 1 | -128,586note 1 | -186,674note 1 | -337,926note 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions.
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 30 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 6 May 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 29 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 9 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 25 Apr 2022
4 registered in CVR.
P-number 1007825796Indertoften 10, 2720 Vanløse
P-number 1027083958Amager Strandvej 405, 2770 Kastrup
P-number 1001077436Amager Strandvej 405, 2770 Kastrup
P-number 1008984804Kay Fiskers Plads 11, 2300 København S
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.
